Liquid Biopsy Market
Global Liquid Biopsy Market: Growth Factor
Main factors fueling the demand for diagnostics using liquid biopsy are growing incidences of lung cancer, gastrointestinal cancer, and breast cancer. Other major factors driving the demand for the global liquid biopsy market are growing inclination of physician and oncologists to opt for diagnostic with non-invasive procedures, the unwillingness of the patients to have painful biopsies and surge in the demand for personalized medicine. Many pharmaceutical and biotechnology companies are aggressively boosting the demand for liquid biopsy for anticancerous drug invention and development. Government funding for research and development in the area of clinical trials for diagnostics, treatments, and prevention of cancers are also driving the global liquid biopsy market. However, higher cost associated with liquid biopsy compared to conventional techniques of diagnostic, and little awareness about liquid biopsy checks pose challenges to the growth of the global liquid biopsy market.
Request Report TOC( Table of Contents) @ https:// www. zionmarketresearch. com / toc / global-liquid-biopsy-market
Global Liquid Biopsy Market: Segmentation
The global liquid biopsy market is fragmented as maker type, sample type, disease indication and end user. On the basis of maker type, the global market is divided as circulating tumor cells, circulating tumor nucleic acids and exosomes. The global liquid biopsy market on basis of sample type is further categorized into urine, blood, plasma, CSF and saliva. Based on disease indication, the global market is further classified into gastrointestinal cancer, breast cancer, lung